Departments of Biological Chemistry and.
Hum Mol Genet. 2014 Feb 15;23(4):843-54. doi: 10.1093/hmg/ddt468. Epub 2013 Sep 24.
Gaucher disease has recently received wide attention due to the unexpected discovery that it is a genetic risk factor for Parkinson's disease. Gaucher disease is caused by the defective activity of the lysosomal enzyme, glucocerebrosidase (GCase; GBA1), resulting in intracellular accumulation of the glycosphingolipids, glucosylceramide and psychosine. The rare neuronopathic forms of GD (nGD) are characterized by profound neurological impairment and neuronal cell death. We have previously described the progression of neuropathological changes in a mouse model of nGD. We now examine the relationship between glycosphingolipid accumulation and initiation of pathology at two pre-symptomatic stages of the disease in four different brain areas which display differential degrees of susceptibility to GCase deficiency. Liquid chromatography electrospray ionization tandem mass spectrometry demonstrated glucosylceramide and psychosine accumulation in nGD brains prior to the appearance of neuroinflammation, although only glucosylceramide accumulation correlated with neuroinflammation and neuron loss. Levels of other sphingolipids, including the pro-apoptotic lipid, ceramide, were mostly unaltered. Transmission electron microscopy revealed that glucosylceramide accumulation occurs in neurons, mostly in the form of membrane-delimited pseudo-tubules located near the nucleus. Highly disrupted glucosylceramide-storing cells, which are likely degenerating neurons containing massive inclusions, numerous autophagosomes and unique ultrastructural features, were also observed. Together, our results indicate that a certain level of neuronal glucosylceramide storage is required to trigger neuropathological changes in affected brain areas, while other brain areas containing similar glucosylceramide levels are unaltered, presumably because of intrinsic differences in neuronal properties, or in the neuronal environment, between various brain regions.
戈谢病由于意外发现其是帕金森病的遗传风险因素而最近受到广泛关注。戈谢病是由于溶酶体酶葡萄糖脑苷脂酶(GCase;GBA1)的活性缺陷导致的,导致细胞内糖鞘脂葡萄糖脑苷脂和神经鞘氨醇积累。戈谢病的罕见神经病变形式(nGD)的特征是严重的神经损伤和神经元细胞死亡。我们之前描述了 nGD 小鼠模型中神经病理学变化的进展。现在,我们在四个不同的大脑区域检查了在疾病的两个无症状前阶段中神经病理学变化的起始与糖鞘脂积累之间的关系,这些区域显示出对 GCase 缺乏的不同程度的易感性。液相色谱-电喷雾电离串联质谱法显示,在神经炎症出现之前,nGD 大脑中存在葡萄糖脑苷脂和神经鞘氨醇积累,尽管只有葡萄糖脑苷脂积累与神经炎症和神经元丧失相关。其他鞘脂的水平,包括促凋亡脂质神经酰胺,大多没有改变。透射电子显微镜显示,葡萄糖脑苷脂积累发生在神经元中,主要以位于核附近的膜限性假小管形式存在。还观察到高度破坏的葡萄糖脑苷脂储存细胞,这些细胞可能是包含大量包涵体、大量自噬体和独特超微结构特征的正在退化的神经元。总之,我们的结果表明,一定水平的神经元葡萄糖脑苷脂储存是触发受影响大脑区域发生神经病理学变化所必需的,而其他含有类似葡萄糖脑苷脂水平的大脑区域则没有变化,这可能是由于不同大脑区域之间神经元特性或神经元环境的内在差异所致。